Vanguard Personalized Indexing Management’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.5M	Sell	215,075 -650	-0.3%	-$52K	0.13%	127
2025 Q4	$20.6M	Sell	215,725 -1,945	-0.9%	-$191K	0.2%	75
2025 Q3	$21.3M	Buy	217,670 +760	+0.4%	+$78.7K	0.22%	72
2025 Q2	$23.3M	Buy	216,910 +37,578	+21%	+$3.8M	0.26%	56
2025 Q1	$18.1M	Buy	179,332 +14,554	+9%	+$1.47M	0.27%	60
2024 Q4	$14.7M	Buy	164,778 +9,057	+6%	+$797K	0.22%	68
2024 Q3	$13M	Buy	155,721 +10,897	+8%	+$859K	0.21%	73
2024 Q2	$11.1M	Buy	144,824 +20,142	+16%	+$1.47M	0.21%	74
2024 Q1	$8.54M	Buy	124,682 +8,903	+8%	+$572K	0.18%	91
2023 Q4	$6.69M	Buy	115,779 +14,497	+14%	+$774K	0.17%	99
2023 Q3	$5.35M	Buy	101,282 +2,333	+2%	+$122K	0.16%	105
2023 Q2	$5.35M	Buy	98,949 +5,205	+6%	+$272K	0.16%	102
2023 Q1	$4.69M	Buy	93,744 +4,439	+5%	+$209K	0.16%	111
2022 Q4	$4.13M	Buy	89,305 +10,928	+14%	+$473K	0.17%	109
2022 Q3	$3.04M	Buy	78,377 +8,031	+11%	+$322K	0.14%	140
2022 Q2	$2.62M	Buy	70,346 +11,450	+19%	+$466K	0.12%	158
2022 Q1	$2.61M	Buy	58,896 +20,604	+54%	+$893K	0.13%	145
2021 Q4	$1.63M	Buy	38,292 +1,251	+3%	+$52.6K	0.1%	218
2021 Q3	$1.61M	Buy	37,041 +4,697	+15%	+$208K	0.14%	138
2021 Q2	$1.38M	Buy	32,344 +13,657	+73%	+$575K	0.14%	145
2021 Q1	$722K	Buy	18,687 +5,181	+38%	+$196K	0.11%	217
2020 Q4	$486K	Buy	13,506 +1,003	+8%	+$36.1K	0.11%	226
2020 Q3	$478K	Buy	12,503 +5,464	+78%	+$211K	0.13%	184
2020 Q2	$247K	Buy	+7,039	New	+$253K	0.11%	245